Antiphospholipid Syndrome clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

    “This research study will take a look at Antiphospholipid Syndrome in order to learn how to better diagnose and control it.”

    open to eligible people ages up to 18 years

    The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

    at UC Davis

  • RAY121 in Immunological Diseases (RAINBOW Trial)

    Sorry, not currently recruiting here

    This Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a inhibitor of classical complement pathway, after multiple dose administration in patients with immunological diseases such as antiphospholipid syndrome (APS), bullous pemphigoid (BP), Behçet's Syndrome (BS), dermatomyositis (DM), immune-mediated necrotizing myopathy (IMNM) and immune thrombocytopenia (ITP).

    at UC Irvine

Our lead scientists for Antiphospholipid Syndrome research studies include .

Last updated: